Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity

Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine

(2016) Chun Yang et al.   PSYCHIATRY RESEARCH

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

(2016) T. Kishimoto et al.   PSYCHOLOGICAL MEDICINE

Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia

(2015) Guillermo Gonzalez-Burgos et al.   BIOLOGICAL PSYCHIATRY

Rapid antidepressant effects and abuse liability of ketamine

(2014) Chun Yang et al.   PSYCHOPHARMACOLOGY

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression

(2014) Kenji Hashimoto   Clinical Psychopharmacology and Neuroscience

R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

(2013) Ji-chun Zhang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

(2012) James W. Murrough et al.   BIOLOGICAL PSYCHIATRY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY